BIFIKAFUSP ALFA
UNII 2K7BN4G2DQ

Substance Identification & Data

This profile provides standardized clinical and technical data for Bifikafusp Alfa, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 2K7BN4G2DQ.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1957239-90-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
2K7BN4G2DQ
CAS Registry Number
1957239-90-5
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
BIFIKAFUSP ALFA
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
10652
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Bifikafusp Alfa. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

BIFIKAFUSP ALFA

Common Names & Synonyms

BIFIKAFUSP ALFA [INN]
BIFIKAFUSP ALFA [WHO-DD]

Systematic Nomenclature

IMMUNOGLOBULIN, ANTI-(HUMAN FIBRONECTIN ED-B DOMAIN) (SYNTHETIC HUMAN CLONE L19 SCFV FRAGMENT) FUSION PROTEIN WITH HUMAN INTERLEUKIN 2